Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
The use of valproic acid and multiple sclerosis.
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Endogenous recovery after brain damage; molecular mechanisms that balance neuronal life/death fate.
Advancing drug delivery systems for the treatment of multiple sclerosis.
The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress.
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Commentary on neuromyelitis optica associated with painful paroxysmal dystonia: case report and literature review.
Placebo and nocebo effects in the neurological practice.
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Determinants of on-the-job-barriers in employed persons with multiple sclerosis: The role of disability severity and cognitive indices.
Partnering to Increase Access to Community Exercise Programs for People With Stroke, Acquired Brain Injury and Multiple Sclerosis.
[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
Obturator neurolysis using 65% alcohol for adductor muscle spasticity.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
Your client has multiple sclerosis: understanding the challenge.
[Productivity and impact of Spanish research into multiple sclerosis (1996-2010)].
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Pages
« first
‹ previous
…
513
514
515
516
517
518
519
520
521
…
next ›
last »